REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/09/2026
Back to search
Official data from USPTO
CBCB-METHOD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CBCB-METHOD
ST13
US500000088404956Class
1, 5, 42
Filing
88404956
Registration
6285669
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/10/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
04/26/2019
Registration date
03/09/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/09/2021
Last transaction
03/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
BERLIN, DE
Examiner
DICKSON, RACHAEL
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SYNBIONIK GMBH
Farmako GmbH
Representatives
Devasena Reddy HM LAW GROUP LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical preparations for industrial and scientific use; biological preparations for industrial and scientific useall the aforesaid goods are for use only with non-consumablenon-medicinalnon-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Class 5
Fungicidesherbicidesantibacterial; flour for pharmaceutical purposes; analgesics; local analgesics; antipyretic analgesics; anti-inflammatory pain patches; analgesic creams; analgesics; universal medical pain-relieving creams; Analgesic pharmaceutical effervescent preparations; Pharmaceutical preparations and substances with analgesic properties; Laxatives; Laxative tablets; Antibiotics; Antiseptics; Veterinary medicinal productsveterinary vaccines; Bath salts for medical purposes; Bath additives in the nature of bath salts for medical purposes; tree bark for pharmaceutical purposes for the treatment of gout; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes for the treatment of cancer; biological preparations for veterinary purposesveterinary vaccines; Dietary foods for medical purposes; protein supplement preparations for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; fats for medical purposes; freeze-dried foodstuffs for medical purposes; homogenised foodstuffs for medical purposes; allergy and diet capsules for medical purposes; allergy and diet capsules for pharmaceutical purposes; chewing gum for medical purposes; mineral waters for medical purposes; mineral water salts for medicinal purposes; wipes soaked with pharmaceutical lotions; mouthwashes for medical purposes; food supplements; Nerve-attenuating pharmaceutical preparations; therapeutic medicated bath preparations; all the aforesaid goods not containing any cannabishemp or CBD
Class 42
pharmaceutical research services of a development and research company in the fields of biotechnologypharmacymedicinediagnostics and chemistry and information technology; productiondevelopment of biotechnologicalpharmaceutical and diagnostic processes and products; Development of processes for the production of chemical substances; chemical laboratory services; chemical technical consultancy; scientific and technological services and research and related design services in the field of pharmaceuticals; industrial analysis and research services to assure compliance with industry standards; design and development of computer software; development of pharmaceutical test methods; product design and development; development of industrial products; pharmaceutical research and development services; development of industrial engineering processes; scientific research and development; industrial pharmaceutical drug development servicesaforesaid services are for use only with non-consumablenon-medicinalnon-therapeutic goods derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Publications
History of USPTO decisions and trademark events.
28 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/15/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/15/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/15/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2020
PUBO
PUBLISHED FOR OPPOSITION
12/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/11/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/11/2020
CNSL
SUSPENSION LETTER WRITTEN
11/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2020
ALIE
ASSIGNED TO LIE
10/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2020
GNRT
NON-FINAL ACTION E-MAILED
04/28/2020
CNRT
NON-FINAL ACTION WRITTEN
04/28/2020
DOCK
ASSIGNED TO EXAMINER
04/16/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/27/2019
DOCK
ASSIGNED TO EXAMINER
05/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2019
NWAP
NEW APPLICATION ENTERED
04/30/2019
Continuous trademark protection
Get notified about every new filing that threatens CBCB-METHOD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.